Abstract View

Author(s): Ms. Harsha S. Suryawanshi1, Ms. Nikita S. Patil2, Mr. Azam Z. Shaikh3, Dr. S. P. Pawar4

Email(s): 1azamph46@gmail.com

Address:

    Department of Pharmaceutics P.S.G.V.P.M’s College of Pharmacy, Shahada

Published In:   Volume - 2,      Issue - 3,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The writing documented may stretch therapy method chemical peels are among the markings (glycolic acid), Tretinoin topical cream, silicon sheets, radio frequency, phototherapy and microdermabrasion lasers, ultraviolet A and B. The risk factors of endocrine metabolic disorders include obesity, pregnancy, fast weight, gain or decrease, aldonsencent development, and extended use of corticosteroids. There is sufficient proof that diet and exercise can’t stop SG. Centella cream a medicinal herb, many work to prevent SG and lesson their severity. In a randomised double-blind placebo controlled trial 183 women are included. Weak date suggest that massaging with almond oil may prevent SG and lesser it’s severity. Other research mentioned here have suggested that using emollient/ cream and may prevent to SG. There is very flimsy that hyaluronic acid lotion like verum and Alphastria can stop SG. According to studies olive oil is ineffective for SG and SG severity reduction.

Cite this article:
Ms. Harsha S. Suryawanshi, Ms. Nikita S. Patil, Mr. Azam Z. Shaikh, Dr. S. P. Pawar. A Review on Effect of Strech Marking in Pregnancy IJRPAS, March-April 2023; 2(2): 1-9


References not available.

Related Images:



Recent Images



Neurological Complications among Pregnant and Post Partum Mothers in a Private Hospital, Yogyakarta, Indonesia
Review on Regulatory Affairs in Pharmaceutical Industry
Cucumber and Mint Soap: Preparation and Evaluation
Topical Delivery in Cosmetics: Enhancing Penetration and Bioavailability
Formulation and Evaluation of Polyherbal Soap
Gelatin: A Widely Used Pharmaceutical Excipient
Therapeutic insights into Saroglitazar: a dual PPAR- α/γ agonist targeting diabetic dyslipidaemia and NAFLD
A Comprehensive Review on Dyslipidemia and Obesity: Pathophysiology, Clinical Implications and Management Approaches
Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview
Review on Clinical Research and Clinical Trials

Tags